Clinical Trial Update: A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of Delgocitinib cream 20 mg/g in adults with palmoplantar pustulosis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Pustulosis

Drugs mentioned

• Delgocitinib cream 20 mg/g (delgocitinib)

Snippet

Sponsor: LEO Pharma | Conditions: Palmoplantar Pustulosis | Phase 2 | Status: RECRUITING